 BETHESDA, Md., Aug. 03, 2021 GLOBE NEWSWIRE -- Gain Therapeutics, Inc. Nasdaq: GANX Gain, a biotechnology company focused on redefining drug discovery by identifying and optimizing novel allosteric binding sites on proteins responsible for neurodegenerative diseases and lysosomal storage disorders, today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present a corporate overview at the BTIG Virtual Biotechnology Conference being held on August 9 10. 